Global Pharmaceuticals Industry Strategic Research Report 2026-2031

Global pharmaceutical consumption -- end-market drug spending -- reached an estimated USD 1.66 trillion in 2025, projected to reach USD 2.45 trillion by 2031, a 6.8% CAGR. This measures the value of drugs actually purchased by patients, insurers, and health systems, structurally distinct from the manufacturing production value covered in the companion Manufacturing report.

North America accounts for an estimated 46.8% of global pharmaceutical consumption but only 36.7% of global pharmaceutical production -- a real, quantified trade deficit of approximately USD 90 billion in 2025, projected to widen to approximately USD 191 billion by 2031. Europe runs the inverse pattern, holding 35.6% of production against only 21.6% of consumption, a net export position of approximately USD 281 billion in 2025.

The GLP-1 category is the clearest current illustration of the structural dynamics reshaping this market: GLP-1/peptide drug market revenue is growing at approximately 10.2% CAGR, while manufacturing capacity for the same category expands at roughly 24.9% CAGR -- an industry racing to build capacity to meet demand that has outpaced supply since the category's earliest commercial years.

This report profiles major integrated innovators including Eli Lilly, Novo Nordisk, Pfizer, Roche, Johnson & Johnson, AstraZeneca, Novartis, Sanofi, Merck, GSK, AbbVie, and Bristol-Myers Squibb, with detailed country-level and therapy-area forecast data through 2031.

Scope of Global Pharmaceuticals Industry Strategic Research Report 2026-2031

• This report provides forecast data by value (USD Billion) for global pharmaceutical consumption, with 2025 as the base year and forecasting to 2031.
• This report provides segmentation by therapy area and by distribution channel.
• This report provides region-wise and country-level forecast data by value.
• This report identifies key growth drivers and inhibitors affecting global pharmaceutical consumption.
• This report provides company profiles for major pharmaceutical innovators.
• This report provides Porter's Five Forces, PESTLE, and SWOT analysis for the global pharmaceutical industry.
• This report identifies key future trends through 2031.

Who can use the Global Pharmaceuticals Industry Research Report?

This research report is ideal for people who wish to gain a thorough understanding of the global pharmaceutical market. Some of the intended users are:

• C-level executives and Company Directors in pharmaceutical companies
• Commercial strategy, payers, investors, and market access teams
• Industry consultants and Management consultants
• Investment managers and Financial professionals
• Anyone operating in the global pharmaceutical value chain.